CC
FLXN

Carlson Capital’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Carlson Capital’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-269,000
Closed -$3.31M – 296
2019
Q2 		$3.31M Sell
269,000
-62,185
-19% -$717K 0.05% 220
2019
Q1 		$4.13M Sell
331,185
-469,458
-59% -$6.27M 0.07% 206
2018
Q4 		$9.06M Buy
800,643
+348,543
+77% +$5.46M 0.14% 200
2018
Q3 		$8.46M Buy
+452,100
New +$10.4M 0.11% 196

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Carlson Capital's FLXN Position: Q3 2019 in Review

Carlson Capital sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2019, closing a stake of 269,000 shares — an estimated $3.31M sold.

Carlson Capital first reported a position in FLXN in Q3 2018 and held it in 4 quarters. The position peaked at $9.06M in Q4 2018. 126 funds tracked by Wall St. Rank hold FLXN as of Q3 2019.

  • Carlson Capital reported no remaining Flexion Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Carlson Capital sold 269,000 Flexion Therapeutics, Inc. shares in Q3 2019, an estimated $3.31M.
  • Carlson Capital first reported a position in Flexion Therapeutics, Inc. in Q3 2018 and held it in 4 quarters.
  • Carlson Capital's Flexion Therapeutics, Inc. position peaked at $9.06M in Q4 2018.
  • 126 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2019.

Based on Carlson Capital's 13F filing for Q3 2019, filed 13 Nov 2019.